Related Experiment Video
Updated: Aug 17, 2026
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Antibody screening and direct antiglobulin testing using BioVue column agglutination technology versus standard tube
1Immunohematology Section, United Blood Services, 6220 East Oak Street, Scottsdale, AZ 85257, USA.
Insights
The BioVue column agglutination technology (CAT) offers a reliable alternative for blood testing. It provides comparable accuracy to standard tube tests (STT) for indirect and direct antiglobulin tests, with significant labor savings.
Area of Science:
- Transfusion Medicine
- Immunology
- Clinical Pathology
Background:
- Indirect antiglobulin testing (IAT) and direct antiglobulin testing (DAT) are crucial in transfusion medicine.
- Standard tube test (STT) methodology is the conventional approach for these tests.
- Evaluating new technologies for efficiency and accuracy is essential.
Purpose of the Study:
- To evaluate the BioVue column agglutination technology (CAT) against standard tube test (STT) for IAT and DAT.
- To compare the sensitivity, specificity, and labor efficiency of CAT versus STT.
- To determine if BioVue CAT is a viable alternative to traditional methods.
Main Methods:
- Simultaneous evaluation of 1,035 blood specimens for IAT and 44 for DAT using both BioVue CAT and STT.
- Utilized polyspecific antiglobulin and anti-IgG antiglobulin reagents in both methodologies.
- Compared sensitivity and specificity results between the two testing methods.
Main Results:
- For IAT, CAT demonstrated 100% sensitivity and 97.9% specificity, while STT showed 99.6% sensitivity and 100% specificity.
- For DAT, both CAT and STT achieved 100% sensitivity and 100% specificity.
- CAT resulted in a 67% labor savings compared to STT.
Conclusions:
- BioVue column agglutination technology (CAT) is a reliable and efficient method for performing IAT and DAT.
- CAT offers comparable diagnostic accuracy to STT for antiglobulin testing.
- The significant labor savings make CAT an attractive alternative for clinical laboratories.
Abstract:
The BioVue column agglutination technology (CAT) was evaluated simultaneously with standard tube test (STT) methodology for use in indirect antiglobulin testing (IAT) and direct antiglobulin testing (DAT). One thousand thirty-five blood specimens were used for the IAT comparison, and 44 blood specimens were used for the DAT comparison. Both polyspecific antiglobulin and anti- IgG antiglobulin reagents were used in the tube testing and the CAT testing. For IAT, sensitivity was 100 percent for CAT and 99.6 percent for STT; sensitivity was 97.9 percent for CAT and 100 percent for STT. In addition, a 67 percent labor savings was realized with CAT versus STT. Specificity and sensitivity of both methodologies were 100 percent for the DAT. BioVue proved to be a reliable and efficient alternative to standard test tube methods for doing IATs and DATs.
